Collegium Announces Master Settlement Agreement Resolving Pending Opioid-Related Litigation
STOUGHTON, Mass., March 30, 2022 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced…
News
INmune Bio, Inc. Announces Company’s CSO Dr. Mark Lowdell to Co-Host the “NK Cells in Solid Tumors” Workshop at Innate Killer Summit
The Company also Plans on Sharing INKmune™ Patient Case Studies Boca Raton, Florida, March 30,…
Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce Platforms
Ji’an, Jiangxi, China, March 30, 2022 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (the “Company”) (Nasdaq:…
Morphic to Participate in BMO Inflammation and Immunology Spotlight Series Panel
WALTHAM, Mass., March 30, 2022 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company…
PepGen Continues to Build Leadership Team with Additions of Senior Vice President, Clinical Operations and Vice President, Toxicology
BOSTON, March 30, 2022 (GLOBE NEWSWIRE) — PepGen, Inc., advancing the next generation of oligonucleotide…
VYNE Reports Positive Preclinical Data for Intra-Articular Injection of Pan-BET Inhibitor, VYN201, in an In Vivo Model of Rheumatoid Arthritis
VYN201 demonstrated statistically significant improvement in treatment response for both endpoints at 1mg/kg and 10mg/kg doses…
Recce Pharmaceuticals Announces Positive Safety Data from Fourth Cohort of Phase I Clinical Trial Evaluating Healthy Subjects Intravenously Dosed with RECCE® 327
Highlights: 10 subjects in cohort four intravenously dosed; RECCE® 327 at 1,000mg, indicating to be…
Immutep’s Efti in Combination with MSD’s Pembrolizumab Shows Encouraging Antitumor Activity in Difficult to Treat 2nd Line Metastatic Lung Cancer Patients
All enrolled patients were 2nd line metastatic non-small cell lung carcinoma (NSCLC) patients that had…
Prometheus Biosciences Initiates Third Phase 2 Study of PRA023 for Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)
– First therapeutic candidate for the treatment of SSc-ILD targeting both key fibrotic and inflammatory…
Biogen Submits Final Protocol for ADUHELM® (aducanumab-avwa) Phase 4 ENVISION Trial to FDA
Confirmatory trial’s completion is expected in an accelerated timeline of four years with patient screening…
Tilray Brands to Announce Third Quarter Fiscal 2022 Financial Results on April 6, 2022
LEAMINGTON, Ontario, March 30, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray Brands” or the…
CENTOGENE Reports Fourth Quarter and Full Year 2021 Financial Results
– Full Year 2021 Total Revenue Growth of 48%, and 11% in Core Business Segments,…
Cognition Therapeutics Reports Year End 2021 Financial Results and Provides Business Update
– Well capitalized from $52 million IPO and $169 million in grant funding –– Established…
Enterprise Centralized Shipping Solution from Elemica Achieves SAP® Certified Integration with SAP HANA®
WAYNE, Pa., March 30, 2022 (GLOBE NEWSWIRE) — Elemica, Inc. announced today that its Enterprise…
WSO2 Announces General Availability of Choreo Digital Platform as a Service
Choreo GA release helps teams take digital apps from ideation to production in days; adds…
Exterro Introduces Free Forensic Imaging Training for Law Enforcement Officers
New FTK Imager Sessions Boost Success Rate in Fighting Crime with Forensic Data PORTLAND, Ore.,…
Borqs Technologies, together with its Subsidiary, Holu Hou Energy, Will Develop and Deliver EV Charger and Smart Home Products
SANTA CLARA, Calif., March 30, 2022 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (Nasdaq: BRQS, “Borqs”,…
WORQDRIVE Democratizes Succession Planning with New Talent Management Module
Innovative Approach Dispels Old Ways of Thinking About Employee Retention Across the Workforce COLUMBUS, Ohio,…
Zenput Adopted by Taco Bell to Drive Operational Excellence
SAN FRANCISCO, March 30, 2022 (GLOBE NEWSWIRE) — Zenput announced today that more than 5,000…
Stock Repurchase by IVRO’s Management Shows Increased Confidence in Future of Non-Animal Testing
Placentia, California–(Newsfile Corp. – March 30, 2022) – InVitro International (OTC PINK: IVRO), a 30+…